BioPharma Drug Discovery

Australia Grants CTA For First In Human KMCAR T Cell Therapy Targeting Multiple Myeloma

Clinical Trial Approval (CTA) granted by Australia’s Therapeutic Goods Administration (TGA) for KMCAR™ T-cell, a first-in-human CAR-T cell th...

 March 18, 2026 | News

Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation

Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...

 March 18, 2026 | News

Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation

Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...

 March 18, 2026 | News

Viva Biotech Advances ActRIIA Targeted Mini Binder Discovery With AI Driven Proteina Complexa Optimisation

Viva Biotech (01873.HK) optimizes the Proteina-Complexa model in advancing the design of mini-binders targeting ActRIIA, a receptor critical...

 March 18, 2026 | News

Hong Kong Approves Ohtuvayre For COPD Maintenance Treatment Under 1 Plus Regulatory Pathway

Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special...

 March 16, 2026 | News

PRISM BioLab And Receptor.AI Partner To Build AI Guided Platform For Challenging Drug Targets

PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc.  announced that they have entered into a drug discovery collaboration agreement (the "Collaborat...

 March 16, 2026 | News

Biophytis And LynxKite Expand AI Drug Discovery Alliance To Advance Next Generation Longevity Therapies

Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This partnership will...

 March 16, 2026 | News

Vimgreen Pharmaceuticals Secures China IND Approval For VG081821 In NASH Clinical Development

Vimgreen Pharmaceuticals, a leading innovator in adenosine signaling modulation, announced the approval of its Investigational New Drug (IND) application f...

 March 16, 2026 | News

Curatis Partners With Neupharma To Advance Corticorelin Development For Brain Tumour Related Edema In Japan

Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developi...

 March 12, 2026 | News

Ascletis Reports Positive Phase II Results For Monthly ASC30 Injection In Obesity Treatment

-    ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of ...

 March 11, 2026 | News

Insilico Medicine AI Discovered CKD Anemia Drug ISM4808 Enters Phase I Clinical Trial

Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced th...

 March 09, 2026 | News

Thermo Fisher Opens Cryo Electron Microscopy Drug Discovery Center In South San Francisco

Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center ...

 March 06, 2026 | News

BrainXell Launches Human iPSC Derived Sensory Neurons Platform To Advance Pain And Ion Channel Research

 BrainXell announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineer...

 March 06, 2026 | News

Senhwa Biosciences And CellType Partner To Advance AI Driven Development Of CX 4945 Cancer Therapy

Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and inf...

 March 05, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close